GB Meka
Stocks to watch

PBH

Compare

PRESTIGE CONSMR HEALTHCARE I · Healthcare

$46.44
▼ 0.6%Close 2026-09-30

Live intraday price

Compare with our price levels

T251.57
T149.86
E144.48
E340.32
SL38.78

Close 2026-09-30: $46.44 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting• Neutral

Not in the buy zone yet — needs to drop 4.2% · 3 whales recently bought

1 month
▼ 10.3%
3 months
▼ 3.6%
1 year
▼ 25.0%
Analyst target
$67.80 +46.0%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$44.48 -4.2%
E2$42.62 -8.2%
E3$40.32 -13.2%
Targets
T1$49.86 7.4%
T2$51.57 11.0%
T3$53.13 14.4%
Stop-loss
SL$38.78 -16.5%
Whale cost ~$55.46 19.4%

Risk : reward 1 : 2.5Moves ~$1.53 a day

⚖️ Positives and risks

✓ Positives (3)
  • ●เซียนซื้อใหม่/ซื้อเพิ่มไตรมาสล่าสุด 3 ราย
  • ●MACD เพิ่งตัดขึ้น (โมเมนตัมเริ่มกลับเป็นบวก)
  • ●ราคาเป้าหมายนักวิเคราะห์เฉลี่ย 67.80 (upside +46%, 5 ราย)
! Risks (3)
  • ●แนวโน้มระยะยาวเป็นขาลง (ใต้ MA200 และ MA200 ชี้ลง)
  • ●อ่อนแอกว่าตลาด (S&P 500) -40% ใน 6 เดือน
  • ●กำไรหดตัว -36% เทียบปีก่อน

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

👔 Insider buying & selling

Latest trades from SEC Form 4 filings

All companies
Sell

Zerillo Jeffrey · Officer

2026-05-11 · 351 shares @ $52.28 · pre-planned sale (10b5-1)

$18,350
Sell

Zerillo Jeffrey · Officer

2026-05-07 · 305 shares @ $54.36 · pre-planned sale (10b5-1)

$16,580
Sell

Zerillo Jeffrey · Officer

2026-05-05 · 1,207 shares @ $54.99

$66,373
Sell

Zerillo Jeffrey · Officer

2026-05-05 · 346 shares @ $55.32 · pre-planned sale (10b5-1)

$19,141
Sell

Zerillo Jeffrey · Officer

2026-02-11 · 1,000 shares @ $65.93

$65,930
Sell

Zerillo Jeffrey · Officer

2025-12-01 · 281 shares @ $60.00 · pre-planned sale (10b5-1)

$16,860
Sell

Zerillo Jeffrey · Officer

2025-11-28 · 719 shares @ $60.00 · pre-planned sale (10b5-1)

$43,140
Sell

BYOM JOHN E · Director

2025-11-25 · 3,000 shares @ $59.35

$178,050

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

No news yet (we only fetch news for stocks with a signal or a high whale score)

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$2.2B
Next earnings2026-11-05
P/E (price to earnings)13.1
Forward P/E (on expected earnings)9.2
Revenue growth (YoY)+6.5%
Earnings growth (YoY)-35.8%
Net profit margin+15.6%
ROE+9.1%
Debt to equity (D/E)108%
Dividend yield-
Analyst targets (high / low)$75.00 / $55.00
Number of analysts5
Trend and technical indicators
Trend short / mid / longDowntrend ↘ · Downtrend ↘ · Downtrend ↘
RSI42
MA50 / MA200$50.07 / $55.72
Distance from MA200-16.6%
MACDJust crossed up
1-year high / low$71.07 / $42.62
vs. S&P 500 (6 months)-40.4%
Volume vs. average0.10×